HPGC Renmintongtai Pharmaceutical Corp
600829
Company Profile
Business description
HPGC Renmintongtai Pharmaceutical Corp, formerly Harbin Pharm. Group Sanjing Pharmaceutical Shareholding Co Ltd is engaged in the production and sale of pharmaceuticals products in China.
Contact
No. 76 Hengshan Road
Nangang District
Heilongjiang Province
Harbin150076
CHNT: +86 45184600888
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2025
Employees
2,870
Stocks News & Analysis
stocks
Market too pessimistic about unloved ASX health care share
Our analysts believe a long-term margin recovery is underway.
stocks
Two overvalued ASX shares to avoid
Both shares trade at a significant premium to our fair value.
stocks
Materially undervalued ASX tech share
Long reinvestment runway supports our thesis on ASX technology company.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,901.20 | 4.60 | -0.05% |
| CAC 40 | 7,959.67 | 21.40 | -0.27% |
| DAX 40 | 23,464.63 | 225.45 | 0.97% |
| Dow JONES (US) | 47,112.45 | 867.04 | 1.87% |
| FTSE 100 | 9,548.03 | 8.32 | 0.09% |
| HKSE | 25,972.26 | 77.71 | 0.30% |
| NASDAQ | 23,025.59 | 752.51 | 3.38% |
| Nikkei 225 | 49,605.57 | 946.05 | 1.94% |
| NZX 50 Index | 13,612.02 | 131.59 | 0.98% |
| S&P 500 | 6,765.88 | 60.76 | 0.91% |
| S&P/ASX 200 | 8,610.20 | 5.80 | -0.07% |
| SSE Composite Index | 3,873.75 | 3.72 | 0.10% |